Exemestaan Sandoz

Exemestane is a medication used to treat certain types of breast cancer. It works by reducing estrogen levels in the body, which can help slow the growth of cancer cells. This oral medication is manufactured by Sandoz B.V. and is available in the EU market.

Exemestane is primarily used in the treatment of breast cancer in postmenopausal women. It is often prescribed for hormone receptor-positive breast cancer, which relies on estrogen to grow. The medication works by inhibiting the enzyme aromatase, which converts androgens into estrogen. This reduction in estrogen levels can help slow the progression of certain types of breast cancer.

Common effects of Exemestane may include joint pain, hot flashes, and fatigue. Some users may also experience nausea, headache, or increased sweating. These effects can vary from person to person and may not affect everyone who takes the medication.

Exemestane should be used with caution in individuals with a history of osteoporosis or liver disease. It is important to discuss any pre-existing conditions with a healthcare provider before starting this medication. Regular monitoring may be recommended to assess bone health and liver function during treatment.

Exemestane may interact with certain medications, including those that affect liver enzymes. It is important to inform a healthcare provider about all medications being taken, including over-the-counter drugs and supplements. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or safety of the medication.